Product Information

ISOTRETINOIN 30 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $5.4277 per EA under NDC 00591243515. Its NADAC has been published 252 times since May 19, 2021.

FDA first approved this application on Mar 31, 2021. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ISOTRETINOIN 30 MG CAPSULE

Isotretinoin
$5.4277per EA

Strength

30 mg/1

NDC

00591243515

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ISOTRETINOIN

Approval Type

Generic (ANDA)

FDA Application

ANDA205063

FDA Approved

3/31/2021

TE Code

AB2

On Market Since

4/29/2021

Pharmacological Classes

Retinoid
Retinoids

Price Statistics

The NADAC for ISOTRETINOIN 30 MG CAPSULE has been published 252 times since May 19, 2021, and over the history we have for it it has risen 46.3%. The table below summarizes its recorded NADAC range and movement.

Current price$5.4277 per EA
All-time high$26.6923 (Jun 15, 2022)
All-time low$3.5783 (Jun 23, 2021)
52-week high$8.8687
52-week low$3.6838
Median price$15.2936
Average price$14.9147
Largest weekly change+646.0% (Jul 21, 2021)
Weeks tracked252
Tracking sinceMay 19, 2021

Price History

1W

0.0%

1M

+21.4%

3M

+35.6%

6M

+12.4%

1Y

-45.1%

3Y

-67.9%

5Y

-79.7%

All

+46.3%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 63% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ISOTRETINOIN 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for ISOTRETINOIN 30 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $5.4277 per EA (NDC 00591243515), effective Nov 11, 2026.

How has the price of ISOTRETINOIN 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for ISOTRETINOIN 30 MG CAPSULE has risen 46.3%. It has been tracked across 252 weekly CMS publications since May 19, 2021.

What are the highest and lowest recorded NADAC prices for ISOTRETINOIN 30 MG CAPSULE?

Since May 19, 2021, the NADAC for ISOTRETINOIN 30 MG CAPSULE has ranged from a low of $3.5783 (Jun 23, 2021) to a high of $26.6923 (Jun 15, 2022), with a median of $15.2936 per EA.

Are there cheaper alternatives to ISOTRETINOIN 30 MG CAPSULE?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ISOTRETINOIN 30 MG CAPSULE, is $2.0102 per EA — about 63% below ISOTRETINOIN 30 MG CAPSULE.

Who manufactures ISOTRETINOIN 30 MG CAPSULE?

ISOTRETINOIN 30 MG CAPSULE (NDC 00591243515) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.